Mitral Valve Prolapse : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
-
Hydralazine adverse reaction
|
Amiodarone is an antiarrhythmic medication that affects the rhythm of heartbeats.
|
|
Class III antiarrhythmic agent; also exhibits activity in each of the 4 Vaughn-Williams antiarrhythmic classes, including some class I (membrane-stabilizing) antiarrhythmic action.
|
|
Hydralazine is a vasodilator that works by relaxing the muscles in your blood vessels to
help them dilate (widen). This lowers blood pressure and allows blood to flow more easily
through your veins and arteries.
|
|
Digoxin helps the heart to beat more strongly and regularly.
|
|
Digoxin is a cardiac glycoside with positive inotropic effects.
|
|
A sulfonamide, loop-type diuretic and antihypertensive agent.
|
|
Vasodilating agent.
|
|
Furosemide is a loop diuretic (water pill) that prevents your body from absorbing too
much salt, allowing the salt to instead be passed in your urine.
|
|
Propranolol is classified as a beta blocker. It is sold in the United States under the brand name Inderal.
|
|
Nonselective β-adrenergic blocking agent.
|
|
Propranolol is in a group of drugs called beta-blockers. Beta-blockers affect the heart and
circulation (blood flow through arteries and veins).
|
|
Wafarin is a vitamin K antagonist that belongs to the family of drugs called anticoagulants ( " blood thinners, " although it does not actually thin the blood). The brand name of warfarin in the U.
|
|
Anticoagulant; a coumarin derivative.
|
|
Warfarin is an anticoagulant (blood thinner). Warfarin reduces the formation of blood
clots.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.